Concepts (76)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dehydration | 1 | 2004 | 21 | 0.260 |
Why?
|
| Hysterectomy, Vaginal | 1 | 2003 | 1 | 0.250 |
Why?
|
| Inpatients | 1 | 2004 | 72 | 0.240 |
Why?
|
| Hospital Costs | 1 | 2003 | 22 | 0.240 |
Why?
|
| Laparoscopy | 1 | 2003 | 54 | 0.230 |
Why?
|
| Hospitalization | 1 | 2004 | 370 | 0.200 |
Why?
|
| Aged | 7 | 2018 | 6448 | 0.200 |
Why?
|
| Mastectomy, Segmental | 2 | 2018 | 18 | 0.190 |
Why?
|
| Breast Neoplasms | 3 | 2018 | 1426 | 0.190 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 31 | 0.170 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2017 | 16 | 0.160 |
Why?
|
| Anticonvulsants | 1 | 2017 | 34 | 0.150 |
Why?
|
| Family Health | 1 | 2016 | 47 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2016 | 592 | 0.140 |
Why?
|
| Mass Screening | 2 | 2010 | 427 | 0.130 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2010 | 375 | 0.130 |
Why?
|
| Hippocampus | 1 | 2017 | 546 | 0.120 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2016 | 790 | 0.120 |
Why?
|
| Length of Stay | 2 | 2004 | 184 | 0.110 |
Why?
|
| Retrospective Studies | 3 | 2017 | 1961 | 0.110 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 2333 | 0.110 |
Why?
|
| Health Behavior | 1 | 2016 | 491 | 0.100 |
Why?
|
| Florida | 2 | 2016 | 358 | 0.080 |
Why?
|
| Mammography | 1 | 2010 | 176 | 0.080 |
Why?
|
| Middle Aged | 6 | 2018 | 9642 | 0.080 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2010 | 248 | 0.070 |
Why?
|
| Fluid Therapy | 1 | 2004 | 27 | 0.060 |
Why?
|
| Costs and Cost Analysis | 1 | 2004 | 54 | 0.060 |
Why?
|
| Humans | 8 | 2018 | 34853 | 0.060 |
Why?
|
| Female | 6 | 2018 | 19873 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2018 | 1349 | 0.060 |
Why?
|
| Adult | 5 | 2017 | 11034 | 0.060 |
Why?
|
| Patient Selection | 1 | 2003 | 154 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2008 | 2561 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2008 | 794 | 0.050 |
Why?
|
| Vigabatrin | 1 | 2017 | 1 | 0.040 |
Why?
|
| Diplopia | 1 | 2017 | 2 | 0.040 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2017 | 4 | 0.040 |
Why?
|
| Lethargy | 1 | 2017 | 2 | 0.040 |
Why?
|
| Vertigo | 1 | 2017 | 3 | 0.040 |
Why?
|
| Ataxia | 1 | 2017 | 8 | 0.040 |
Why?
|
| Sclerosis | 1 | 2017 | 6 | 0.040 |
Why?
|
| Carbamazepine | 1 | 2017 | 5 | 0.040 |
Why?
|
| Dizziness | 1 | 2017 | 7 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2018 | 322 | 0.040 |
Why?
|
| Benzodiazepines | 1 | 2017 | 13 | 0.040 |
Why?
|
| Valproic Acid | 1 | 2017 | 14 | 0.040 |
Why?
|
| Triazines | 1 | 2017 | 19 | 0.040 |
Why?
|
| Fructose | 1 | 2017 | 23 | 0.040 |
Why?
|
| Receptor, erbB-2 | 1 | 2018 | 122 | 0.040 |
Why?
|
| Amines | 1 | 2017 | 38 | 0.040 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2017 | 70 | 0.040 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2016 | 16 | 0.040 |
Why?
|
| Vision Disorders | 1 | 2017 | 59 | 0.040 |
Why?
|
| Propensity Score | 1 | 2016 | 40 | 0.040 |
Why?
|
| Hormone Replacement Therapy | 1 | 2016 | 41 | 0.040 |
Why?
|
| Young Adult | 2 | 2017 | 4012 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 142 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2017 | 288 | 0.040 |
Why?
|
| Socioeconomic Factors | 2 | 2010 | 1003 | 0.030 |
Why?
|
| Risk Factors | 2 | 2016 | 3414 | 0.030 |
Why?
|
| Genomics | 1 | 2016 | 201 | 0.030 |
Why?
|
| Life Style | 1 | 2016 | 288 | 0.030 |
Why?
|
| United States | 2 | 2016 | 3894 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2016 | 311 | 0.030 |
Why?
|
| Male | 3 | 2017 | 18870 | 0.030 |
Why?
|
| Sickness Impact Profile | 1 | 2010 | 20 | 0.020 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2010 | 52 | 0.020 |
Why?
|
| Women's Health | 1 | 2010 | 135 | 0.020 |
Why?
|
| Marital Status | 1 | 2008 | 35 | 0.020 |
Why?
|
| Comorbidity | 1 | 2010 | 606 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2008 | 429 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 894 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 5035 | 0.020 |
Why?
|
| Educational Status | 1 | 2008 | 295 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2008 | 583 | 0.010 |
Why?
|